More patients are coming to see me in London with the same concern. They have lost weight, sometimes with the help of GLP-1 medications like Ozempic or Mounjaro and they feel healthier for it. But their face tells a different story. Cheeks look hollow, the skin around the jaw has started to sag and they look tired even when they are not.
This is what has become known online as “Ozempic face.” It is not a diagnosis and it is not unique to Ozempic. It is what happens when the face loses fat faster than the skin can adapt.
Key Takeaways
- “Ozempic face” describes facial volume loss and skin laxity that can happen during rapid weight loss, including with GLP-1 medications.
- The face has less fat than the rest of the body, so it often shows the effects of weight loss first and most visibly.
- The right approach depends on timing. Prevention works differently to correction after volume has already been lost.
- Dermal fillers, biostimulators and skin boosters each play a different role and using the wrong one at the wrong time can look overdone.
- A full-face assessment before you start losing weight is the most effective way to plan ahead and avoid a sudden, aged appearance.
- Treatment should always be carried out by a qualified medical professional working from a full-face assessment, not a single feature in isolation.
What Is Ozempic Face?
“Ozempic face” is a term that has spread quickly on social media to describe a gaunt, aged appearance that can follow rapid or significant weight loss, particularly with newer weight loss medications such as semaglutide (Ozempic, Wegovy), a GLP-1 receptor agonist and tirzepatide (Mounjaro), a dual GIP and GLP-1 receptor agonist.
The face is one of the few areas of the body where fat plays a structural role, not just a cosmetic one. It supports the skin, holds the cheeks up and softens the transition between features. When that fat volume drops quickly, the skin does not always have time to adjust. The result can be:
- Hollowing in the cheeks and temples
- Loose or crepey skin around the jaw and neck
- Deeper nasolabial folds
- A more pronounced, sometimes “sunken” appearance around the eyes
- Skin laxity that makes the face look older than the rest of the body suggests
This is not a side effect exclusive to any one drug. It is a predictable consequence of losing facial fat quickly and it can happen with any significant or rapid weight loss.
Why the Face Is Affected First
Most of the body has room to lose fat gradually and evenly. The face does not work the same way. Facial fat sits in distinct compartments that provide structure and support. Once that volume is gone, there is very little padding left to lose, so changes tend to show up early and can look disproportionate to weight loss elsewhere.
This is also why treating “Ozempic face” is not simply a case of replacing lost volume anywhere it is missing. A full-face assessment looks at how the compartments interact, so structure is restored in proportion rather than filled in isolated spots.
How to Avoid Ozempic Face: A Preventative Approach
If you are starting or already on a GLP-1 medication, the most effective time to plan for your face is before significant volume loss occurs, not after.Understanding how to prevent Ozempic face early is far easier than correcting it later.
A preventative approach usually includes:
- A baseline full-face assessment, understanding your current facial structure and where you are likely to lose volume first.
- Skin quality support early, using biostimulators and skin boosters that encourage the skin’s own collagen and elasticity, so it is better prepared to adapt as weight changes.
- Monitoring through the weight loss journey, rather than waiting until hollowing or sagging is already visible.
- Timed, conservative intervention, with small, proportionate adjustments as needed, rather than one large correction after the fact.
This is a different approach to correcting volume loss that has already happened, which is why timing your consultation matters.
Correcting Ozempic Face After Volume Loss
If hollowing or skin laxity has already developed, correction is still very possible. The approach depends on what is actually happening in the face, which is why an in-person assessment matters more than guessing based on a mirror. Dermal fillers for Ozempic face are one of the most common starting points, since they restore lost structural volume directly, but they are rarely the only answer.
Options may include:
- Dermal fillers to restore structural volume in the cheeks, temples or jawline
- Biostimulators to support the skin’s own collagen production over time, rather than just adding volume
- Skin boosters to improve hydration and elasticity in skin that has lost some of its bounce
- Combination approaches, where volume and skin quality are addressed together for a more natural result
The goal is never to “fill” the face back to how it looked before. It is to support the structure that is there now, so the result looks like a healthier, more rested version of you, not a different face.
Is It Safe to Treat Ozempic Face?
When performed by a qualified medical professional following a proper assessment, treating volume loss and skin laxity has a strong safety profile. As with any injectable treatment, outcomes depend heavily on practitioner experience, product choice and technique.
This is one of the reasons a full-face assessment matters so much here. Treating a single hollow area without understanding how the rest of the face has changed can create imbalance rather than solve it. The British Association of Aesthetic Plastic Surgeons advises that a practitioner should “provide proof of their qualifications, level of training, and amount of experience” in the procedure being carried out.
Depending on your skin quality and how much structural support you need, treatment may draw on approaches such as dermal fillers for volume restoration or Profhilo for skin elasticity and hydration.
Who Should Consider This?
You may benefit from a preventative or corrective consultation if you:
- Are currently taking or planning to start a GLP-1 medication
- Have lost a significant amount of weight quickly, for any reason
- Have noticed hollowing, sagging or a more tired appearance in your face
- Want a plan in place before changes become more visible
Frequently Asked Questions
Ozempic face describes facial volume loss and skin laxity that can happen during rapid weight loss, including with GLP-1 medications. It is not a medical diagnosis, but a descriptive term for a visible pattern.
You can avoid Ozempic face by getting a full-face assessment before or early in your weight loss, followed by proactive skin quality support rather than waiting until volume loss is visible.
Volume loss around the mouth and lower face can change how the lips and perioral area appear, which is sometimes described online in relation to teeth. This is part of the same overall pattern of facial volume loss, not a separate condition.
Not necessarily. With the right assessment and treatment plan, volume and skin quality can often be restored, though results depend on individual anatomy and how much change has occurred.
Not always. Some patients benefit most from biostimulators or skin boosters that support the skin itself, while others need structural volume. This is why a full-face assessment comes before any treatment recommendation.
Ready to Have an Honest Conversation?
Book a Consultation with Dr Zack Ally
At Sculpt Clinic, consultations begin with a full-face assessment, not a quick fix for one area. If you are on a weight loss journey and want a plan for how your face will be supported along the way, we would like to hear from you.
Book Your ConsultationDisclaimer
This article is for general information and does not replace a medical consultation. GLP-1 medications and their effects vary by individual and any decision to start, continue or stop treatment should be made with your prescribing doctor. Aesthetic treatment to support facial volume and skin quality should only be carried out following a full assessment by a qualified medical practitioner. Individual results vary.